Skip to content

Pro-Dex, Inc. PDEX Return on equity

Return on equity at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
26.4%-3.0pp
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
6.1%-1.2pp
Medtronic logo
MedtronicMDT
9.8%+0.4pp
InfuSystem Holdings logo
InfuSystem HoldingsINFU
13.9%+8.0pp
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-13.4%-4.6pp
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
2.2%+1.1pp

Other financials

Income statement

See full
Revenue$19.9M+14.6%
Gross profit$6.1M+5.8%
Operating income$3.1M-15.0%
Net income$3.9M+20.2%
EPS (diluted)$1.20+22.4%

Balance sheet

See full
Cash & equivalents$10.0M+123%
Total debt$16.0M+43.2%
Total equity$45.2M+28.1%
Total assets$75.0M+16.7%

Cash flow

See full
Operating cash flow$1.6M+488%
CapEx$112.0K-37.8%
Free cash flow$1.5M

Valuation

See full
Market cap$195.81M+39.3%
Enterprise value$201.8M+34.4%
P/E16.3×+0.7×
P/S2.6×+0.5×

Profitability

See full
Gross margin27.8%-3.6pp
Operating margin14.5%-3.8pp
Net margin16.1%+1.5pp
FCF margin-3.8%+3.2pp

Returns & leverage

See full
Debt / equity0.4×0.0×
Current ratio3.7×+0.9×

Where this comes from

Calculated from Pro-Dex, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Pro-Dex, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pro-Dex, Inc.'s return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pro-Dex, Inc.'s return on equity?
Pro-Dex, Inc. (PDEX) reported return on equity of 29.8% in Q1 2026.
How has Pro-Dex, Inc.'s return on equity changed year-over-year?
Pro-Dex, Inc.'s return on equity increased by 5.4% year-over-year, from 28.3% to 29.8%.
What is the long-term trend for Pro-Dex, Inc.'s return on equity?
Over 4 years (2021 to 2025), Pro-Dex, Inc.'s return on equity has grown at a -3.5% compound annual growth rate (CAGR), from 30.7% to 26.6%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.